AST SpaceMobile CTO Unveils 160,000 Share Sale Plan in 10-Q/A
Ticker: ASTS · Form: 10-Q/A · Filed: Sep 12, 2025 · CIK: 1780312
Sentiment: bearish
Topics: AST SpaceMobile, 10-Q/A, Insider Trading, Rule 10b5-1 Plan, Executive Stock Sales, Space Technology, Satellite Communications
Related Tickers: ASTS
TL;DR
**ASTS CTO's 160,000 share sale plan is a red flag for investors, signaling potential insider bearishness despite no financial changes.**
AI Summary
AST SpaceMobile, Inc. filed a 10-Q/A on September 12, 2025, to amend its Quarterly Report for the fiscal quarter ended June 30, 2025. The primary purpose of this amendment was to disclose a previously omitted Rule 10b5-1 trading arrangement entered into by Dr. Huiwen Yao, the Company's Chief Technology Officer. This plan, established on June 12, 2025, allows for the sale of up to 160,000 shares of Class A Common Stock and is set to remain in effect until September 16, 2026, or until all trades are executed. The filing explicitly states that no financial statements were amended or included, and the amendment does not reflect any events after the original filing date of August 11, 2025. New certifications from the Principal Executive Officer, Abel Avellan, and Principal Financial Officer, Andrew M. Johnson, were included as exhibits, as required by Rule 12b-15 of the Exchange Act. The company's Class A common stock, with a par value of $0.0001 per share, is traded on The Nasdaq Stock Market LLC under the symbol ASTS.
Why It Matters
This 10-Q/A reveals a significant Rule 10b5-1 sales plan by AST SpaceMobile's CTO, Dr. Huiwen Yao, for up to 160,000 shares of Class A Common Stock. While these plans are common for executives to manage personal finances, a large sale by a key technology leader could be perceived by investors as a lack of confidence, potentially impacting stock sentiment. Competitors in the satellite-to-phone space will be watching how this disclosure affects ASTS's market valuation and investor perception, especially given the capital-intensive nature of the industry. Employees might also view this as a signal regarding the company's near-term trajectory, though the filing itself doesn't alter the company's financial position.
Risk Assessment
Risk Level: medium — The risk level is medium because the filing discloses a Rule 10b5-1 sales plan for up to 160,000 shares by the CTO, Dr. Huiwen Yao, which could be interpreted negatively by the market. While the filing explicitly states no financial statements were amended, the sale by a key executive, particularly the Chief Technology Officer, can create investor uncertainty regarding future prospects.
Analyst Insight
Investors should monitor ASTS's stock performance closely for any downward pressure following this disclosure. While the filing doesn't change fundamentals, the optics of a CTO selling 160,000 shares could lead to short-term volatility. Consider this a data point for insider sentiment, but do not solely base investment decisions on this single event.
Executive Compensation
| Name | Title | Total Compensation |
|---|---|---|
| Dr. Huiwen Yao | Executive Vice President, Chief Technology Officer | |
| Abel Avellan | Chairman and Chief Executive Officer, Principal Executive Officer | |
| Andrew M. Johnson | Chief Financial Officer and Chief Legal Officer, Principal Financial Officer |
Key Numbers
- 160,000 — shares of Class A Common Stock (maximum shares Dr. Huiwen Yao plans to sell under 10b5-1 plan)
- June 12, 2025 — date (when Dr. Huiwen Yao entered the 10b5-1 sales plan)
- September 16, 2026 — date (latest expiration date for Dr. Huiwen Yao's 10b5-1 sales plan)
- 269,127,705 — Class A common stock shares (issued and outstanding as of August 7, 2025)
- 11,227,292 — Class B common stock shares (issued and outstanding as of August 7, 2025)
- 78,163,078 — Class C common stock shares (issued and outstanding as of August 7, 2025)
- $0.0001 — par value per share (for Class A, B, and C common stock)
Key Players & Entities
- AST SpaceMobile, Inc. (company) — registrant filing the 10-Q/A
- Dr. Huiwen Yao (person) — Chief Technology Officer who entered a Rule 10b5-1 sales plan
- Abel Avellan (person) — Chairman and Chief Executive Officer, Principal Executive Officer
- Andrew M. Johnson (person) — Chief Financial Officer and Chief Legal Officer, Principal Financial Officer
- SEC (regulator) — Securities and Exchange Commission
- Nasdaq Stock Market LLC (company) — exchange where ASTS Class A common stock is registered
- 160,000 (dollar_amount) — number of Class A Common Stock shares in Dr. Yao's sales plan
- June 30, 2025 (date) — end of the fiscal quarter for the amended report
- August 11, 2025 (date) — date of the Original Filing of the 10-Q
- September 16, 2026 (date) — expiration date of Dr. Yao's 10b5-1 sales plan
FAQ
Why did AST SpaceMobile file a 10-Q/A on September 12, 2025?
AST SpaceMobile filed the 10-Q/A to amend its Quarterly Report for the fiscal quarter ended June 30, 2025, specifically to add disclosure about a Rule 10b5-1 trading arrangement entered into by Dr. Huiwen Yao, the Chief Technology Officer, which was inadvertently omitted from the original filing.
What is the key change in AST SpaceMobile's 10-Q/A filing?
The key change is the disclosure of a Rule 10b5-1 sales plan by Dr. Huiwen Yao, the Chief Technology Officer, entered into on June 12, 2025, for the sale of up to 160,000 shares of the Company's Class A Common Stock.
Who is Dr. Huiwen Yao at AST SpaceMobile?
Dr. Huiwen Yao is AST SpaceMobile's Executive Vice President and Chief Technology Officer, and he is the executive who entered into the disclosed Rule 10b5-1 sales plan.
How many shares are involved in Dr. Huiwen Yao's 10b5-1 sales plan for AST SpaceMobile?
Dr. Huiwen Yao's Rule 10b5-1 sales plan involves the potential sale of up to 160,000 shares of AST SpaceMobile's Class A Common Stock.
When does Dr. Huiwen Yao's 10b5-1 sales plan for AST SpaceMobile expire?
The Yao 10b5-1 Sales Plan will remain in effect until the earlier of September 16, 2026, the date all trades are executed, or its termination according to its terms.
Were AST SpaceMobile's financial statements changed in this 10-Q/A?
No, the filing explicitly states that no financial statements have been included or amended in this Amendment No. 1 on Form 10-Q/A.
What is the significance of a Rule 10b5-1 plan for AST SpaceMobile investors?
A Rule 10b5-1 plan allows insiders to sell shares at predetermined times to avoid accusations of insider trading. For investors, a large plan, like Dr. Yao's 160,000 shares, can signal an executive's personal financial planning or, potentially, a perceived lack of upside, which could influence market sentiment.
Who certified the AST SpaceMobile 10-Q/A filing?
The 10-Q/A was certified by Abel Avellan, Chairman and Chief Executive Officer, and Andrew M. Johnson, Chief Financial Officer and Chief Legal Officer, as required by the Securities Exchange Act Rules.
What is the par value of AST SpaceMobile's common stock?
The par value for AST SpaceMobile's Class A, Class B, and Class C common stock is $0.0001 per share.
Where is AST SpaceMobile's Class A common stock traded?
AST SpaceMobile's Class A common stock, with the trading symbol ASTS, is registered and traded on The Nasdaq Stock Market LLC.
Risk Factors
- Rule 10b5-1 Trading Plan Disclosure [medium — regulatory]: The amendment addresses an inadvertently omitted Rule 10b5-1 trading arrangement for Dr. Huiwen Yao, the CTO. This plan allows for the sale of up to 160,000 shares of Class A Common Stock. Failure to properly disclose such plans can lead to regulatory scrutiny and potential penalties.
- Executive Officer Stock Sales [medium — operational]: The disclosure of Dr. Huiwen Yao's plan to sell up to 160,000 shares of Class A Common Stock could be interpreted by the market as a signal of potential insider concerns, although the plan is structured to comply with Rule 10b5-1. The timing and volume of these sales could impact stock price volatility.
Industry Context
AST SpaceMobile operates in the nascent but rapidly evolving satellite-to-mobile connectivity sector, aiming to provide ubiquitous broadband coverage via a constellation of satellites directly communicating with standard mobile phones. The industry is highly capital-intensive and faces significant technological hurdles, with key competitors also developing similar direct-to-device satellite services. Regulatory approvals for spectrum usage and satellite operations are critical for market entry and expansion.
Regulatory Implications
The amendment highlights the importance of accurate and timely disclosure of executive trading plans under SEC rules like 10b5-1 and 12b-15. Inadvertent omissions can lead to increased regulatory scrutiny and potential enforcement actions. Compliance with these disclosure requirements is crucial for maintaining investor confidence and avoiding penalties.
What Investors Should Do
- Monitor Dr. Huiwen Yao's stock sales.
- Review the original Form 10-Q for financial details.
- Assess the company's compliance procedures.
Key Dates
- 2025-06-12: Dr. Huiwen Yao entered into a Rule 10b5-1 sales plan. — This plan allows for the sale of up to 160,000 shares of Class A Common Stock and was a key reason for the 10-Q/A filing.
- 2025-06-30: Fiscal quarter ended. — The period covered by the original Form 10-Q and the amended filing.
- 2025-08-11: Original Form 10-Q filed. — This is the initial quarterly report that was later amended.
- 2025-09-12: Form 10-Q/A (Amendment No. 1) filed. — This amendment disclosed the previously omitted Rule 10b5-1 trading arrangement and included new executive certifications.
- 2026-09-16: Latest expiration date for Dr. Huiwen Yao's 10b5-1 sales plan. — Indicates the maximum duration for the planned sale of up to 160,000 shares by the CTO.
Glossary
- Rule 10b5-1 trading arrangement
- A written trading plan that meets specific requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, allowing insiders to buy or sell company stock at a predetermined time or based on a predetermined formula, providing an affirmative defense against insider trading allegations. (This is the primary subject of the amendment, detailing Dr. Huiwen Yao's plan to sell up to 160,000 shares.)
- Form 10-Q/A
- An amendment to a previously filed Form 10-Q (Quarterly Report). It is used to correct or supplement information previously reported. (This filing is an amendment to the original Form 10-Q for the quarter ended June 30, 2025, specifically to add disclosure about an executive's trading plan.)
- Rule 12b-15
- A rule from the Securities Exchange Act of 1934 that governs the requirements for filing amendments to registration statements and reports, including the need for new certifications from principal officers. (This rule mandated the inclusion of new certifications from the CEO and CFO in this amendment.)
- Class A common stock
- The publicly traded shares of AST SpaceMobile, Inc., with a par value of $0.0001 per share, traded on the Nasdaq under the symbol ASTS. (The shares that Dr. Huiwen Yao plans to sell under the Rule 10b5-1 plan are of this class.)
Year-Over-Year Comparison
This filing is an amendment (10-Q/A) to the original Form 10-Q filed on August 11, 2025, and does not contain updated financial statements or reflect events after the original filing date. Therefore, a direct comparison of key financial metrics like revenue, net income, or margins to the previous year is not possible based on this amendment alone. The primary change is the disclosure of Dr. Huiwen Yao's Rule 10b5-1 trading plan, which was inadvertently omitted from the original filing.
Filing Stats: 1,188 words · 5 min read · ~4 pages · Grade level 12.7 · Accepted 2025-09-12 17:14:23
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share ASTS The Nasdaq Stock Mar
Filing Documents
- asts-20250630.htm (10-Q/A) — 86KB
- asts-ex31_1.htm (EX-31.1) — 9KB
- asts-ex31_2.htm (EX-31.2) — 9KB
- 0000950170-25-114605.txt ( ) — 2151KB
- asts-20250630.xsd (EX-101.SCH) — 1363KB
- asts-20250630_htm.xml (XML) — 18KB
– OTHER INFORMATION
PART II – OTHER INFORMATION
Othe r Information
Item 5. Othe r Information. Director and Executive Officer Trading Plans In the quarter ended June 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or any non-Rule 10b5-1 trading arrangement for the purchase or sale of our securities, within the meaning of Item 408 of Regulation S-K, except as follows: On June 12, 2025 , Dr. Huiwen Yao , the Company's Executive Vice President, Chief Technology Officer , entered into a Rule 10b5-1 sales plan (the "Yao 10b5-1 Sales Plan") intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act for the sale of up to 160,000 shares of the Company's Class A Common Stock. The Yao 10b5-1 Sales Plan will remain in effect until the earlier of (1) September 16, 2026 , (2) the date on which all trades set forth in the Yao 10b5-1 Sales Plan have been executed, or (3) such time as the Yao 10b5-1 Sales Plan is otherwise terminated according to its terms. ii
Exhibits
Item 6. Exhibits The following exhibits are filed as part of, or incorporated by reference into, this Amendment. 31.1* Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 31.2* Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 101.INS Inline XBRL ("iXBRL") for the information under Part II, Item 5, "Other Information" of this Amendment No. 1 on Form 10-Q/A 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith iii SIGNAT URES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. AST SPACEMOBILE, INC. Date: September 12, 2025 By: /s/ Abel Avellan Name: Abel Avellan Title: Chairman and Chief Executive Officer Principal Executive Officer Date: September 12, 2025 By: /s/ Andrew M. Johnson Name: Andrew M. Johnson Title: Chief Financial Officer and Chief Legal Officer Principal Financial Officer 4